Company: RPID
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001380106-25-000174
Chunk: 18

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-08-12
Form: 10-Q
Item: Part I, Item 2
Chunk 18
---
.

Costs and operating expenses 

Costs of revenue

Cost of product revenue increased $0.3 million, or 2.5%. The increase was driven by higher consumables sales volume (net of the impact of one fewer system placement) as well as higher inventory reserves in the current year period

Cost of service revenue decreased by $0.4 million, or 10.6%. This decrease was primarily attributable to lower headcount and headcount-related costs due in part to productivity improvements.

Research and development

Six Months EndedJune 30,Change20252024Amount%(dollars in thousands)Research and development$6,854 $7,586 $(732)(9.6)%Percentage of total revenue47.4 %62.0 %

Research and development expenses decreased by $0.7 million, or 9.6%. The decrease was primarily driven by lower headcount and headcount-related costs as well as the timing of spending related to new product development activities.

Sales and marketing

Six Months EndedJune 30,Change20252024Amount%(dollars in thousands)Sales and marketing$5,865 $6,908 $(1,043)(15.1)%Percentage of total revenue40.5 %56.5 %

Sales and marketing expenses decreased by $1.0 million, or 15.1%. This decrease was primarily due to lower headcount-related and third-party consulting costs.  

General and administrative

Six Months EndedJune 30,Change20252024Amount%(dollars in thousands)General and administrative$11,769 $11,445 $324 2.8 %Percentage of total revenue81.4 %93.6 %

General and administrative expenses increased by $0.3 million, or 2.8%. This increase was primarily attributable to higher non-cash stock compensation expense, partially offset by a reduction in public company operating expenses.  

Other income (expense) 

Interest income

Interest income decreased $1.0 million, or 55.1% due to lower investment balances.

41

Other expense

Other expense, which is comprised of miscellaneous expenses unrelated to our core business, was flat for each of the six months ended June 30, 2025 and 2024. 

Income tax expense (benefit) 

Income tax expense was less than $0.1 million for each of the six months ended June 30, 2025 and 2024. The expense in each period